Screener
ImmunityBio, Inc. IBRX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
FAQ
- What is ImmunityBio, Inc.'s short-term investments?
- ImmunityBio, Inc. (IBRX) reported short-term investments of $175.69M in Q1 2026.
- How has ImmunityBio, Inc.'s short-term investments changed year-over-year?
- ImmunityBio, Inc.'s short-term investments increased by 18770.6% year-over-year, from $931K to $175.69M.
- What is the long-term trend for ImmunityBio, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s short-term investments has grown at a 20.4% compound annual growth rate (CAGR), from $61.15M to $154.48M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about ImmunityBio, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude